Browsing Tag
AbbVie acquisition
2 posts
AbbVie acquires Celsius Therapeutics to enhance inflammatory disease treatment options
In a significant move within the biotechnology industry, AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, has completed…
AbbVie completes acquisition of Landos Biopharma to strengthen immunology portfolio
AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has announced the completion of its acquisition of Landos Biopharma,…